Company Overview and News
M&A activity has been big part of the global market for the past few years now, and that’s likely to continue. Tax reform has freed up more cash and made potential targets more accretive. The economy is humming along. And in a few key sectors — consumer goods and media come to mind — there’s an obvious logic behind consolidation.
TXN GRA TWX MS.PRE MS.PRF MS.PRG MS.PRA WMT WFM ERIC SFM HON AVGO CSCO NOK MS MXIM AA FOX GD SQ LGF HAIN UTX ARNC TWC HRL MAT MS.PRI GOOGL ERI MS.PRK PENN MSFT LVS BA QCOM BB FOXA GCP XLNX LMT MGM FB MTSI PNK RAD CPB PYPL AVAV GOOG FIZZ KR AMCX 6723 KO RNECY MSGN CIEN DIS HON WYNN CMCSA RNECF MA COL BMRN SNY RHT TGT V HAS PEP DPS T ADI KHC LGF.A LGF.B
Consumer staples has been one of the most cast-off sectors of the 2010s, and many companies are trading at cheap multiples.
WFCNP GIS PG CPB WFC.PRL WFC.PRJ WMT WFC.PRT CVGW WFC.PRR TSNU WFC.PRQ WFC.PRP WFC.PRO CL WFC.PRN KO WFC.PRY WFC.PRX TSN WFC.PRW WFC.PRV WFC WFC.WS PSCC BRK.A VGT KHC FLO DF
Food companies have long served as a source of recession-proof profits and increasing dividends. However, stocks such as Kellogg Company (NYSE:K) and its peers have come under increasing pressure over the last few years. Revenues have trended downward as consumers buy fewer packaged foods. Kellogg’s has responded to this and Kellogg stock has seen modest success.
GIS CPB KHC K
The Coca-Cola Company (NYSE:KO) stock has been mostly dead money for the past year. Then again, consumer staples stocks have been under tremendous pressure lately because of changes in consumer tastes and the relentless impact of digital platforms, such as Amazon.com, Inc. (NASDAQ:AMZN). Companies like Colgate-Palmolive Company (NYSE:CL), General Mills, Inc. (NYSE:GIS) and Campbell Soup Company (NYSE:CPB) have suffered double-digit losses in their share prices during this period.
SAP GIS AMZN SAPGF CL WDAY CPB KO
Campbell Soup Co. (NYSE: CPB) shares saw a nice bounce on Tuesday after activist investor Dan Loeb was said to be shaking things up. Loeb’s message seems pretty simple and is an appropriate measure considering the direction in which the soup maker has been headed recently.
Restaurant stocks have been a tricky industry for investors over the past year. But because the economy remains strong, these stocks should do well. After all, what’s one thing people like to do when they have a little extra cash? They like to go out and grab something to eat. It’s a little luxury.
WEN TXRH CPB BWLD SBUX MCD
Monday was a brutal day for the stock market. The S&P 500, Dow Jones Industrial Average and Nasdaq Composite fell about 2% on the day. While most stocks fell on the day, Campbell Soup Company (NYSE:CPB) wasn’t one of them … instead, CPB stock climbed almost 10% on the day.
IBM GIS CPB AAPL KHC NYTAB
Believe it or not, not every stock was trashed on Monday. Campbell Soup (NYSE:CPB) managed a 9% advance on the heels or reports that rival Kraft Heinz (NASDAQ:KHC) was planning to make an acquisition offer.
BAC MMC CPB KHC AXP NFLX NYTAB HOG
Campbell Soup (NYSE:CPB) was surging Monday on news that Kraft Heinz (NASDAQ:KHC) may buyout the company.
WFC WFCNP WFC.WS GIS CPB WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN KHC WFC.PRY WFC.PRX WFC.PRW WFC.PRV
Monday was a down day for the broad U.S. markets with each of the major exchanges dropping over 1% on the day. The Nasdaq was the worst of the group reaching below 2% to close out the day. Crude oil was pushed back as well, retreating to $68. The S&P 500 sectors were almost entirely negative. The most positive sectors were utilities and consumer staples, up 1.7% and 0.5%, respectively. The worst performing sectors were consumer discretionary and energy, down 2.
NDAQ CUKPF CPB CCL CCL CUK
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to CPB / Campbell Soup Co. on message board site Silicon Investor.
|Speculating in Takeover Targets||CPB Campbell soup|
as of ET